Source: James Cancer Hospital and Solove Research Institute
Tamoxifen is one of the most commonly used medications in the battle against breast cancer, but according to doctors, as many as 40 percent of women will become resistant to the drug after five years.
However, a new drug called Vismodegib could prove helpful. Researchers at Ohio State's Comprehensive Cancer Center discovered it obstructs a pathway that allows some cancer cells to circumvent Tamoxifen and also destroys those cells.
"You may have a new treatment combination that is just a pill. Both are pills that you would take. You don't have to lose hair for the most part and you feel well overall and you have another treatment option," said Dr. Bhuvana Ramaswamy from James Cancer Hospital.
FOX 2's Deena Centofanti has more in the video report.
WJBK-TV | Fox 2
Didn't find what you were looking for?